The CD73 immune checkpoint promotes tumor cell metabolic fitness
eLife · 01.06.2023 · 12
DOI: 10.7554/elife.84508 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 01.06.2023. Verfasst von David Allard und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre de Recherche du Centre Hospitalier l'Université de Montréal, Montreal, Canada. Hauptthemen laut MEDLINE: Aspartic Acid, Neoplasms. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research, Fonds de recherche du Québec.
Abstract (Originalsprache)
CD73 is an ectonucleotidase overexpressed on tumor cells that suppresses anti-tumor immunity. Accordingly, several CD73 inhibitors are currently being evaluated in the clinic, including in large randomized clinical trials. Yet, the tumor cell-intrinsic impact of CD73 remain largely uncharacterized. Using metabolomics, we discovered that CD73 significantly enhances tumor cell mitochondrial respiration and aspartate biosynthesis. Importantly, rescuing aspartate biosynthesis was sufficient to restore proliferation of CD73-deficient tumors in immune deficient mice. Seahorse analysis of a large panel of mouse and human tumor cells demonstrated that CD73 enhanced oxidative phosphorylation (OXPHOS) and glycolytic reserve. Targeting CD73 decreased tumor cell metabolic fitness, increased genomic instability and suppressed poly ADP ribose polymerase (PARP) activity. Our study thus uncovered an important immune-independent function for CD73 in promoting tumor cell metabolism, and provides the rationale for previously unforeseen combination therapies incorporating CD73 inhibition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre de Recherche du Centre Hospitalier l'Université de Montréal, Montreal, Canada.
- Faculté de Pharmacie, Université de Montréal, Montreal, Canada.
- Institut du Cancer de Montréal, Montreal, Canada.
- McGill Goodman Cancer Research Centre, Montréal, Canada.
ORCID-Profile: John Stagg
Förderung
- Canadian Institutes of Health Research
- Fonds de recherche du Québec
Zitieren
APA
Allard, D., Cousineau, I., Ma, E. H., Allard, B., Bareche, Y., Fleury, H., & Stagg, J. (2023). The CD73 immune checkpoint promotes tumor cell metabolic fitness. eLife, 12. https://doi.org/10.7554/elife.84508
Vancouver
Allard D, Cousineau I, Ma EH, Allard B, Bareche Y, Fleury H, et al. The CD73 immune checkpoint promotes tumor cell metabolic fitness. eLife. 2023;12. doi:10.7554/elife.84508
BibTeX
@article{Allard2023,
author = {Allard, David and Cousineau, Isabelle and Ma, Eric H and Allard, Bertrand and Bareche, Yacine and Fleury, Hubert and Stagg, John},
title = {The CD73 immune checkpoint promotes tumor cell metabolic fitness},
journal = {eLife},
year = {2023},
volume = {12},
doi = {10.7554/elife.84508}
}
EUVIMED